FDA Inspection
CorneaGen, LLCCorneaGen, LLC – FDA Inspection, Jul 20, 2018
Record Details
This FDA Inspection record concerns CorneaGen, LLC, with an inspection on July 20, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 6319f14a-8037-434b-b4c1-17288fdbe7f9
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1061992
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of CorneaGen, LLC
7| Date | Classification | Office | Project area |
|---|---|---|---|
| September 16, 2026 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| May 31, 2023 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| July 14, 2021 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| October 22, 2015 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| February 28, 2014 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for CorneaGen, LLC
- FDA Inspection 1337312 - 2026-09-16
- FDA Inspection 1207713 - 2023-05-31
- FDA Inspection 1149011 - 2021-07-14
- FDA Inspection 946041 - 2015-10-22
- FDA Inspection 870037 - 2014-02-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.